Elon Musk claimed on Wednesday he expects a wi-fi brain chip  developed by his company Neuralink to start out human scientific trials in six months, following the firm missed earlier timelines set by him.

The company is producing brain chip interfaces that it suggests could help disabled patients to shift and converse yet again, with Musk introducing on Wednesday it will also target restoring eyesight.

Dependent in the San Francisco Bay Spot and Austin, Texas, Neuralink has in new a long time been conducting assessments on animals as it seeks acceptance from the U.S. Food items and Drug Administration (Food and drug administration) to get started clinical trials in people.

“We want to be really careful and specified that it will get the job done properly right before placing a machine into a human,” Musk claimed during a much-awaited public update on the device.

Talking to a crowd of pick invitees in a presentation at Neuralink headquarters that lasted nearly three hours, Musk emphasized the velocity at which the business is producing its gadget.

“The progress at very first, specially as it applies to people, will appear to be potentially agonizingly slow, but we are undertaking all of the points to provide it to scale in parallel,” he additional. “So, in concept, development really should be exponential.”

The Food and drug administration claimed it can not remark on the standing or the existence of any prospective product or service applications.

The first two human apps targeted by the Neuralink unit will be in restoring vision and enabling motion of muscle tissues in people who cannot do so, Musk reported. “Even if someone has under no circumstances experienced vision, at any time, like they have been born blind, we believe we can still restore vision,” he mentioned.

The occasion was at first prepared for Oct. 31 but Musk postponed it just days ahead of without providing a rationale.

Neuralink’s previous public presentation, more than a 12 months back, associated a monkey with a brain chip that played a laptop or computer video game by imagining on your own.

Musk, who also runs electrical automobile manufacturer Tesla, rocket agency SpaceX, and social media system Twitter, is regarded for lofty plans these types of as colonizing Mars and saving humanity. His ambitions for Neuralink, which he introduced in 2016, are of the same grand scale.

He wishes to produce a chip that would make it possible for the mind to regulate sophisticated electronic gadgets and finally allow for people with paralysis to regain motor purpose and treat brain ailments this sort of as Parkinson’s, dementia and Alzheimer’s. He also talks of melding the brain with synthetic intelligence.

Neuralink, however, is running behind agenda. Musk explained in a 2019 presentation he was aiming to obtain regulatory acceptance by the conclude of 2020. He then explained at a convention in late 2021 that he hoped to commence human trials this year.

Neuralink has consistently skipped interior deadlines to get Fda acceptance to start off human trials, latest and previous employees have reported.

Musk approached competitor Synchron previously this yr about a probable investment soon after he expressed aggravation to Neuralink workforce about their sluggish development, Reuters described in August.

Synchron crossed a important milestone in July by implanting its machine in a affected individual in the United States for the initially time. It acquired U.S. regulatory clearance for human trials in 2021 and has done reports in four individuals in Australia.